Pharmacogenomics Journal

杂志介绍

Pharmacogenomics Journal杂志介绍

《Pharmacogenomics Journal》是一本以English为主的未开放获取国际优秀期刊，中文名称药物基因组学杂志，本刊主要出版、报道医学-遗传学领域的研究动态以及在该领域取得的各方面的经验和科研成果，介绍该领域有关本专业的最新进展，探讨行业发展的思路和方法，以促进学术信息交流，提高行业发展。该刊已被国际权威数据库SCI、SCIE收录，为该领域相关学科的发展起到了良好的推动作用，也得到了本专业人员的广泛认可。该刊最新影响因子为2.8，最新CiteScore 指数为5.7。

本刊近期中国学者发表的论文主要有：

• Tumour immune cell infiltration and response to FOLFOX or FOLFIRI chemotherapy in colorectal cance

  Author: Feng, Jia; Zhang, Lei; Liao, Zhijun; Zou, You; Liu, Rong

• KHSRP promotes the malignant behavior and cisplatin resistance of bladder cancer cells through the CLASP2/MAPRE1 axi

  Author: Wang, Ruizhe; Zhao, Cheng; Ou, Zhenyu; Chen, Lingxiao

英文介绍

Pharmacogenomics Journal杂志英文介绍

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.

Key areas of coverage include:

Personalized medicine

Effects of genetic variability on drug toxicity and efficacy

Identification and functional characterization of polymorphisms relevant to drug action

Pharmacodynamic and pharmacokinetic variations and drug efficacy

Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics

Clinical applications of genomic science

Identification of novel genomic targets for drug development

Potential benefits of pharmacogenomics.